ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,011.50
-1.33%
S&P 500
5,509.01
0.62%
Dow Jones
39,331.85
0.41%
US Dollar vs Yen
161.4955
-0.01%
Brent Oil
86.445
-0.10%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Turnstone Biologics Corporation (TSBX)

  7. Turnstone Biologics Corporation (TSBX) ニュース

TSBX

Turnstone Biologics (TSBX)

Turnstone Biologics Corporation
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:TSBX
日付受信時刻ニュースソース見出しコード企業名
2024/06/0606 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSBXTurnstone Biologics Corporation
2024/06/0105 : 23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TSBXTurnstone Biologics Corporation
2024/05/1406 : 15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TSBXTurnstone Biologics Corporation
2024/05/1406 : 05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TSBXTurnstone Biologics Corporation
2024/05/1406 : 03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSBXTurnstone Biologics Corporation
2024/05/1406 : 01GlobeNewswire Inc.Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business HighlightsNASDAQ:TSBXTurnstone Biologics Corporation
2024/05/0822 : 00GlobeNewswire Inc.Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care ConferenceNASDAQ:TSBXTurnstone Biologics Corporation
2024/04/1622 : 00GlobeNewswire Inc.Turnstone Biologics Appoints William Waddill to its Board of DirectorsNASDAQ:TSBXTurnstone Biologics Corporation
2024/03/2206 : 06GlobeNewswire Inc.Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:TSBXTurnstone Biologics Corporation
2024/03/0522 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSBXTurnstone Biologics Corporation
2024/02/2120 : 00GlobeNewswire Inc.Turnstone Biologics to Participate in Upcoming Investor ConferencesNASDAQ:TSBXTurnstone Biologics Corporation
2024/02/2107 : 00GlobeNewswire Inc.Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.NASDAQ:TSBXTurnstone Biologics Corporation
2023/11/2720 : 00GlobeNewswire Inc.Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:TSBXTurnstone Biologics Corporation
2023/11/1011 : 49GlobeNewswire Inc.Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:TSBXTurnstone Biologics Corporation
2023/11/0319 : 00GlobeNewswire Inc.Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:TSBXTurnstone Biologics Corporation
2023/10/3019 : 00GlobeNewswire Inc.Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. WeberNASDAQ:TSBXTurnstone Biologics Corporation
2023/10/1807 : 42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TSBXTurnstone Biologics Corporation
2023/10/1807 : 41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TSBXTurnstone Biologics Corporation
2023/10/1807 : 38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TSBXTurnstone Biologics Corporation
2023/10/1807 : 37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TSBXTurnstone Biologics Corporation
2023/10/1807 : 36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TSBXTurnstone Biologics Corporation
2023/10/1807 : 34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TSBXTurnstone Biologics Corporation
2023/09/2819 : 00GlobeNewswire Inc.Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer’s (SITC) 38th Annual MeetingNASDAQ:TSBXTurnstone Biologics Corporation
2023/09/0206 : 57GlobeNewswire Inc.Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:TSBXTurnstone Biologics Corporation
2023/09/0205 : 39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TSBXTurnstone Biologics Corporation
2023/07/2115 : 15GlobeNewswire Inc.Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public OfferingNASDAQ:TSBXTurnstone Biologics Corporation
 Showing the most relevant articles for your search:NASDAQ:TSBX

最近閲覧した銘柄

COIN
SOLUSD
Solana
NYSE
KO
Coca Cola
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
ADDYY
Adidas (QX)
COIN
BTCUSD
Bitcoin
AMEX
XLV
Health Care Select Sector
USOTC
RHHBY
Roche (QX)
NYSE
MRK
Merck
FX
USDGBP
US Dollar vs Sterling
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
TSLA
Tesla
CCOM
US500
US 500
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
GOOGL
Alphabet
PM
XAUUSD
Gold vs US Dollar
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有